Alverine Citrate

Alverine Citrate

What is Alverine Citrate?

Alverine Citrate is an anti-spasmodic medicine that relieves the pain from intestinal cramps often caused by Irritable Bowel Syndrome (IBS). It works by relaxing the tensed muscles that are causing pain. 

What is Alverine?

Alverine is an antispasmodic medication used to treat intestinal disorders such as irritable bowel syndrome (IBS). Alverine offers effective relief from painful symptoms of IBS. 

How does Alverine work?

Alverine works to relax the muscles that surround the intestines and uterus to reduce stomach cramping.

Is Alverine right for me?

If you suffer from painful episodes of stomach cramping, Alverine could be the right medication for you. Consult your physician for the best treatment options.

Side Effects

All medications can cause potential side effects, below we have listed some potential side effects, however these do not always occur.

  • Dizziness, 
  • Headache
  • Feelings of sickness
  • Allergic reactions (itching or rashes)

Dosage

Commonly Used Dosage Guidelines for Alverine

For 120mg strength tablets: take 1 capsule 1-3 times daily, preferably 20 minutes before meals

For 60mg strength tablets: take 1 or 2 tablets up to 3 times daily, preferably 20 minutes before meals.

Alverine Patient Leaflet

To view Alverine Patient Leaflet click here.

To view PDF patient leaflet click here.

Disclaimer


The information provided in this blog post is intended for general informational purposes only and should not be considered as medical advice, diagnosis, or treatment. Welzo does not endorse or sell the medication discussed, nor do we recommend using this information as a substitute for professional healthcare. Always consult with a qualified healthcare provider before making any decisions regarding your health or medical treatment. Welzo assumes no responsibility for any actions taken based on the information provided in this blog.

Share article
Get 10% off your first order

Plus get the inside scoop on our latest content and updates in our monthly newsletter.